SLS Management’s Allergan plc AGN Stock Holding History

SLS Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,400	Closed	-$2.13M	–	11
2017 Q3	$2.13M	Buy	+10,400	New	+$2.42M	2.78%	10

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

SLS Management's AGN Position: Q4 2017 in Review

SLS Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 10,400 shares — an estimated $2.13M sold.

SLS Management first reported a position in AGN in Q3 2017 and held it in 1 quarter. The position peaked at $2.13M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

SLS Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
SLS Management sold 10,400 Allergan plc shares in Q4 2017, an estimated $2.13M.
SLS Management first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
SLS Management's Allergan plc position peaked at $2.13M in Q3 2017.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on SLS Management's 13F filing for Q4 2017, filed 13 Feb 2018.